Vaccine development can be really expensive, and there’s limited commercial return.
Articles on Ebola vaccine
Displaying 1 - 20 of 25 articles
There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding offers hope.
The Bundibugyo strain of Ebola causing the ongoing outbreak in the Democratic Republic of Congo currently has no vaccine. The Conversation Weekly podcast speaks to two researchers working to develop one.
While other forms of Ebola can be prevented with a vaccine, none are currently available to prevent this rare strain.
The outbreak in the Democratic Republic of the Congo has claimed 28 lives, including four health workers. Here’s what it means for those in the region and beyond.
Breastfeeding mothers and their babies have largely been neglected in Ebola research. This needs to change.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
The biggest lesson has been that controlling a disease outbreak like Ebola is impossible without community trust and engagement.
CC BY-NC-ND5.58 MB (download)
African researchers are on the front line of the fight to find a vaccine that will protect people against Ebola.
Uganda is the testing ground for a new vaccine that could work on more strains of the Ebola virus and other haemorrhagic fevers.
Alarm arose when news spread that Ebola cases had been found in Uganda. Here are the real reasons for concern.
The current Ebola outbreak in the DRC is devastating vulnerable communities already affected by displacement and violence.
Four new Ebola treatments are being tried out in the DRC.
The new Ebola vaccine is yet to be licensed but evidence shows that it protects against the strain of the virus.
Without the current experimental vaccine the Ebola outbreak in the DRC has the potential to spiral out of control.
Instability in the DRC and Ebola’s deadly properties is making it hard to contain the virus.
There have been ten Ebola outbreaks recorded from the DRC between 1976 and 2018 from different locations. This implies that the virus is widely spread.
Teams administering the Ebola vaccine in the Democratic Republic of Congo are in a race against time to find and help people exposed.
The final trials of the first effective Ebola vaccine show it’s safe to use against an outbreak.
In the future, consumers in the developed world could choose to purchase products from the companies that do the most to promote global health.
Top contributors
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Principal Medical Scientist (PhD MPH), National Institute for Communicable Diseases
-
Lecturer in Virology, Queen's University Belfast
-
Postdoctoral Researcher, Oxford Vaccine Group, University of Oxford
-
Calleva Head of Vaccine Immunology, University of Oxford
-
Associate Professor of Medicine, UMass Chan Medical School
-
Professor of Microbiology, Faculty of Medicine, University of Kinshasa
-
Professor, University of Warwick
-
Head of the Center for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases
-
Adjunct Professor, Faculty of Law, L’Université d’Ottawa/University of Ottawa
-
Ph.D. Candidate in Chemical Biology, Harvard University
-
PhD candidate, MRC Centre for virus research, University of Glasgow
-
Professor of Philosophy, Binghamton University, State University of New York
-
Professor of Microbiology, Faculty of Medicine, University of Kinshasa
-
Professor of Life Sciences, University of Warwick